Rethinking molecular diagnostics
EFIRM (electric field induced release and measurement) is EZLife Bio's core for performing accurate disease testing. EFIRM is robust, rapid, PCR-free,and sample extraction free: electrochemical biosensors are effectively leveraged to streamline testing.
Only a drop (20 uL) of blood or saliva is needed to achieve nearly perfect detection of targets in as little as 30 minutes. As a company, EZLife Bio is poised to reshape and radically simplify how testing is done.Read more about the science behind EFIRM
EZLife Bio's system offers a complete solution from sample to answer. Saliva can be placed in the EFIRM96 Device for rapid detection of biomarkers. Finally, this data can be uploaded to the EZLife EasyData platform for rapid data and result reporting.Read more about our product
EFIRM: Versatility and power combined
Non-invasively monitoring of biomarkers to track treatment response and recurrence
Unparalled ability to detect biomarkers, even in early stage disease
The only platform to work on both blood and saliva
E Coli or S. Aureus easily analyzed from a small amount of specimen
Allows easy measurement of hormone and health indicators
Versatile detection of a wide panel of novel markers
Capable of being deployed in limited resource settings
Easy to use platform for analytical chemistry and nanotechnology research
Founded in 2016, EZLife Bio rethinks how molecular diagnostics is done with the EFIRM technology. Our platform is user-friendly, with precise and accurate product assertions backed by rigorous scientific data. At EZLife Bio, we hope to transofrm the landscape of molecular testing.
EFIRM is the world leader in being able to simultaneously detect DNA and protein based targets.
EZLife Bio Transforming Molecular Diagnostics